These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12358850)

  • 1. Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression.
    Perosa F; Prete M; Luccarelli G; Favoino B; Dammacco F
    Eur J Immunogenet; 2002 Oct; 29(5):409-12. PubMed ID: 12358850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype.
    Perosa F; Prete M; Luccarelli G; Favoino B; Ferrone S; Dammacco F
    Hum Immunol; 1999 Nov; 60(11):1058-66. PubMed ID: 10600003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
    Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
    Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis.
    Wong-Baeza I; Ridley A; Shaw J; Hatano H; Rysnik O; McHugh K; Piper C; Brackenbridge S; Fernandes R; Chan A; Bowness P; Kollnberger S
    J Immunol; 2013 Apr; 190(7):3216-24. PubMed ID: 23440420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2.
    Wang X; Liang B; Rebmann V; Lu J; Celis E; Kageshita T; Grosse-Wilde H; Ferrone S
    Tissue Antigens; 2003 Aug; 62(2):139-48. PubMed ID: 12889994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two human monoclonal antibodies recognizing HLA-A30 and HLA-A3 + A31, respectively.
    Mazzoleni O; Pistillo MP; Falco M; Tazzari PL; Ferrara GB
    Tissue Antigens; 1991 Nov; 38(5):224-7. PubMed ID: 1780844
    [No Abstract]   [Full Text] [Related]  

  • 7. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.
    Migliaresi S; Bresciani A; Ambrosone L; Spera M; Barbarulo D; Lombari V; Pirozzi G; Borgia G; Lombardi ML; Tirri G; Manzo C
    Ann Rheum Dis; 2000 Jan; 59(1):20-5. PubMed ID: 10627422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-micro-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta2-micro-associated HLA class I heavy chain levels and HLA phenotype.
    Puppo F; Bignardi D; Contini P; Hamby CV; Brenci S; Lanza L; Ghio M; Scudeletti M; Indiveri F; Ferrone S
    Tissue Antigens; 1999 Mar; 53(3):253-62. PubMed ID: 10203018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.
    Desai SA; Wang X; Noronha EJ; Zhou Q; Rebmann V; Grosse-Wilde H; Moy FJ; Powers R; Ferrone S
    J Immunol; 2000 Sep; 165(6):3275-83. PubMed ID: 10975844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
    Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
    Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens.
    Puppo F; Brenci S; Contini P; Bignardi D; Hamby CV; Filaci G; Ghio M; Scudeletti M; Picciotto A; Indiveri F; Ferrone S
    Tissue Antigens; 2000 Apr; 55(4):333-41. PubMed ID: 10852385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of human leucocyte antigen class I free heavy chains on monocytes of patients with spondyloarthritis and cells transfected with HLA-B27.
    Ding J; Feng Y; Zheng ZH; Li XY; Wu ZB; Zhu P
    Int J Immunogenet; 2015 Feb; 42(1):4-10. PubMed ID: 25545293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma.
    Perosa F; Prete M; Luccarelli G; Dammacco F
    Br J Haematol; 2003 Jan; 120(1):36-43. PubMed ID: 12492574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.
    Koelman CA; Vaessen LM; Balk AH; Weimar W; Doxiadis II; Claas FH
    Transpl Immunol; 2000 Mar; 8(1):57-64. PubMed ID: 10834611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between murine beta 2-microglobulin and HLA class I heavy chains results in serologically detectable conformational changes of both chains.
    Ferrier P; Layet C; Caillol DH; Jordan BR; Lemonnier FA
    J Immunol; 1985 Aug; 135(2):1281-7. PubMed ID: 2409144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of human monoclonal antibodies for monitoring donor derived soluble HLA class I molecules in the serum of heart transplant recipients.
    Koelman CA; Mulder A; Jutte NH; Vaessen LM; Balk AH; Weimar W; Doxiadis II; Claas FH
    Hum Immunol; 1998 Feb; 59(2):106-14. PubMed ID: 9536433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.